Autologous platelet-rich plasma in women with Asherman's syndrome

Intrauterine infusion of autologous platelet-rich plasma in women with Asherman's syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110509006420N17

Enrollment

Registered

2018-08-02

Start date

2018-07-23

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asherman Syndrome. Intrauterine synechiae

Interventions

Intervention 1: Intervention group: Releasing adhesions and injections of 1 cc PRP( platelets reached plasma ) into the uterine cavity. Intervention 2: Control group: Hysteroscopy and adhesion releas

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: All patients with Asherman's syndrome who have been diagnosed with ultrasound, sonography, hysterography or hysteroscopy.

Exclusion criteria

Exclusion criteria: Severe cervical stenosis Coagulation disorders Mullerian anomaly systemic disorders

Design outcomes

Primary

Measure	Time frame
Adhesion scoring. Timepoint: 4 to 6 weeks after hysteroscopy. Method of measurement: With hysteroscopy & ASRM score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Eftekhar

Yazd University of Medical Sciences

Eftekharmaryam@yahoo.com+98 35 3824 2563

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026